Eli Perencevich, MD, MS

MD: Case Western Reserve School of Medicine, 1994
MS Epidemiology: Harvard School of Public Health, 2001
Internal Medicine Residency: New York Hospital-Cornell Medical Center Chief
Residency: NYU Downtown Hospital Infectious Disease
Fellowship: Beth Israel Deaconess Medical Center

Phone: 410-706-0063
Fax: 410-706-0098

Dr. Perencevich is a practicing infectious disease physician and is board certified in Internal Medicine and Infectious Disease. He is also the Associate Hospital Epidemiologist for the University of Maryland Medical System. His research interests include the epidemiology of antibiotic resistant pathogens in hospital setting, mathematical modeling of infectious pathogens and cost-effectiveness analysis. He currently is supported by a VA HSR&D Research Career Development award to study the cost-effectiveness of active surveillance for vancomycin-resistant enterococci on admission to the hospital and intensive care unit. He currently is a co-investigator charged with completing the cost-effectiveness analyses for a large 20-ICU clinical trial assessing VRE control methods sponsored by the Bacteriology and Mycology Study Group of the National Institutes of Health (N01-A1-15440) and has served for 2 years on the USDA National Advisory Committee on Microbiological Criteria for Foods.

RECENT PUBLICATIONS:

Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R, The Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge. Emerg Infect Dis. Feb 2003 9(2):196-203.

Kim PW, Harris AD, Roghmann MC, Morris JG, Strinivasan A, Perencevich EN. A Comparison of the Risk Factors for Recovery of Ceftriaxone Susceptible and Resistant Citrobacter freundii among Hospitalized Patients Antimicrob Agents Chemother. 2003 Sep;47(9):2882-7.

Perencevich EN, Kaye KS, Strausbaugh LJ, Fisman DN, Harris AD, and the Infectious Diseases Society of America Emerging Infections Network. Acceptable Treatment Failure Rates in Osteomyelitis Involving the Diabetic Foot: A Survey of Infectious Disease Physicians. Clin Infect Dis. 2004, Feb 15: 38(4): 476-82.

Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Smith DL. Projected Benefits of Active Surveillance for Vancomycin-Resistant Enterococci in ICU Settings. Clin Infect Dis. 2004, Apr 15: 38(8):1108-15.

Harris AD, Bradham DD, Mona Baumgarten M, Ilene H Zuckerman IH, Fink JC, Perencevich EN. The Use and Interpretation of Quasi-Experimental Studies in Infectious Diseases. Clin Infect Dis. 2004, Jun 1: 38(11):1586-91.

Back to Secondary Faculty

To contact us:

Phone: 410-706-7560
Fax: 410-706-4619
E-mail: kvardjan@ihv.umaryland.edu

Back to Top of Page